Rising Zoonotic Diseases Fuel The Growth Of The Cat Vaccine Market : A Significant Driver Propelling The Cat Vaccine Market In 2025

The Cat Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Cat Vaccine Market Size and Projected Growth Rate?
The size of the cat vaccine market has seen considerable growth in the recent past. An increase from $1.15 billion in 2024 to $1.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3%, is projected. Key factors driving this upward trend include the rise in new feline diseases, growing prevalence of illnesses in animals, expansion of the livestock population, a rise in companion animal numbers and an increase in zoonotic diseases.

The market size for cat vaccines is expected to witness robust expansion over the upcoming years, reaching a valuation of $1.78 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%. The anticipated growth during the forecast period is largely driven by the increasing trend of pet adoption, higher disposable income levels, the rising demand for veterinary services, interventions by governments and veterinary organizations, as well as an increased awareness about animal health. Notable trends projected for the forecasted period entail the creation of enhanced cat vaccinations, ground-breaking and more efficient vaccine technologies and products, developments in combination vaccines, as well as the advent of personalized vaccine programs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20526

What Are the Major Segments in the Cat Vaccine Market?
The cat vaccine market covered in this report is segmented -

1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types
2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Diseases
3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
4) By Route Of Administration: Injectables, Intranasal, Oral
5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers

Subsegments:
1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine
2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine
3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp

What Are The Driving Cat Vaccine Market Evolution?
The rise in zoonotic diseases is anticipated to drive the growth of the cat vaccine market. Zoonotic diseases, which are infections transmitted from animals to humans through pathogens such as bacteria, viruses, fungi, or parasites, can be spread through direct contact, vector transmission, or exposure to contaminated environments. Some of the common zoonotic diseases include Lyme disease, rabies, toxoplasmosis, salmonellosis, brucellosis, among others. Factors such as climate change, antibiotic resistance, and both illicit and legal wildlife commerce have contributed to the surge in zoonotic diseases. By diminishing the likelihood of transmission from cats to humans through vaccination against diseases like toxoplasmosis and cat scratch fever, cat vaccines can help control zoonotic diseases. This proactive strategy reduces the disastrous effects of zoonotic diseases on human health, augments public health initiatives, and creates a healthier environment for pets and their caregivers. For example, a report from the UK Government in February 2024 cited an increase in confirmed cases of Lyme disease in England in the fourth quarter of 2023, with 335 cases as compared to 273 in the same period in 2022. Thus, the escalating zoonotic diseases are accelerating the cat vaccine market.

Which Firms Dominate The Cat Vaccine Market Segments?
Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale, Virbac, Neogen Corporation, Indian Immunologicals Ltd., Jinyu Bio-technology Co. Ltd., Ourofino Animal Health SA, Biogénesis Bagó SA, Valley Vet Supply, HIPRA Corporation, Bioveta AS, China Animal Husbandry Group, Veterinary Pharmaceutical Solutions, Torigen Pharmaceuticals Inc., KM Vet Pharm Sdn Bhd.

What Trends Are Expected to Dominate the Amnion Patch Market in the Next 5 Years?
Leading players in the cat vaccine market are centering their efforts on the development of new and innovative products like the NOBIVAC NXT vaccines, which employ cutting-edge Ribonucleic acid (RNA)-particle technology to strengthen immune responses and boost vaccine effectiveness. This technology encapsulates RNA molecules within nanoparticles to transport genetic instructions to cells. Consequently, these cells produce specific proteins that evoke a specific immune response. In the month of June 2024, MSD Animal Health Inc., an American pharmaceutical company, introduced the NOBIVAC NXT Rabies portfolio, which includes NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. This comprehensive vaccination solution is designed to offer robust protection against rabies for both cats and dogs. Crafted without adjuvants and preservatives, the NOBIVAC NXT vaccines prioritize safety without sacrificing effectiveness. By stimulating both humoral (antibody-mediated) and cell-mediated immune responses, these vaccines assure wide-ranging defense against the rabies virus.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report

Which Is The Largest Region In The Cat Vaccine Market?
North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cat Vaccine Market?
2. What is the CAGR expected in the Cat Vaccine Market?
3. What Are the Key Innovations Transforming the Cat Vaccine Industry?
4. Which Region Is Leading the Cat Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the cat vaccine market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.